Global DNA/RNA Extraction Kit Market Research Report 2021-2026: Increasing Investments in Research and Development of Molecular Diagnostics Driving Growth
11 août 2021 04h48 HE
|
Research and Markets
Dublin, Aug. 11, 2021 (GLOBE NEWSWIRE) -- The "DNA/RNA Extraction Kit Market - Growth, Trends, COVID-19 Impact, and Forecast (2021 - 2026)" report has been added to ResearchAndMarkets.com's...
Circulating DNA/RNA Patent Landscape Report 2021: Oppositions and Litigations, Key Patent Analysis, Patent Database
05 juil. 2021 06h53 HE
|
Research and Markets
Dublin, July 05, 2021 (GLOBE NEWSWIRE) -- The "Circulating DNA/RNA Patent Landscape 2021" report has been added to ResearchAndMarkets.com's offering. Circulating nucleic acids tests, an essential...
Inivata to Present Data at AACR Virtual Annual Meeting Highlighting Capabilities and Clinical Application of RaDaR™ Assay
22 juin 2020 09h32 HE
|
Inivata
Inivata to Present Data at AACR Virtual Annual Meeting Highlighting Capabilities and Clinical Application of RaDaR™ Assay Personalized assay for detection of residual disease and recurrence...
Precipio Announces Third Quarter 2018 Revenues Estimated to be 2.4 Times Third Quarter of 2017 Revenues
16 oct. 2018 07h47 HE
|
Precipio, Inc.
Fourth consecutive Quarter of Triple-Digit Year-over-Year Quarterly Revenue Growth; Year-to-Date Revenues Increased 163% over First Three Quarters of 2017 NEW HAVEN, Conn., Oct. 16, 2018 (GLOBE...
Precipio Strengthens Patent Portfolio with Expanded Kit Claims for its Liquid Biopsy Enabling DNA Mutation Enrichment Technology
06 juin 2018 07h38 HE
|
Precipio, Inc.
NEW HAVEN, Conn., June 06, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced the award of US patent No. 9,957,556 entitled FULL COLD-PCR...
Exosome Diagnostics Launches the MedOncAlyzer™ Pan-Cancer Panel
09 août 2017 09h02 HE
|
Exosome Diagnostics
Waltham, Mass., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, a leader in the liquid biopsy market, today announced the launch of the MedOncAlyzer 170, the first liquid biopsy pan-cancer...
Breakthrough Technology Spurs New Test for Non-Small Cell Lung Cancer Patients
05 nov. 2015 15h18 HE
|
ARUP Laboratories
SALT LAKE CITY, Nov. 5, 2015 (GLOBE NEWSWIRE) -- For a patient battling lung cancer, the discomforts and risks of undergoing repeated biopsies, surgeries, and radiologic scans can now be replaced by a...